GlassScriptPhysician profile
Laura P Wolfe
NPI 1669739967
$1,295.15
in general payments reported to CMS, 2019-2025
20 companies · $167 in 2025
The $167 reported for 2025 was more than what a typical Obstetrics & Gynecology provider received nationally (typical 2025 total: $158).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $405 · 2020: $170 · 2021: $157 · 2022: $194 · 2023: $127 · 2024: $74.51 · 2025: $167.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $369.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $368.83 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $378.10 | 2019-2022 | |
| Hologic Sales and Service, LLC | $148.63 | 2019-2025 | Aptima, Thinprep 2000 Processor, Sonata Sonography-Guided Transcervical Fibroid Ablation System |
| Bayer Healthcare Pharmaceuticals INC. | $140.95 | 2019-2025 | |
| Astellas Pharma US INC | $80.28 | 2023-2025 | Veozah |
| Medtronic, INC. | $79.24 | 2021 | |
| Intuitive Surgical, INC. | $76.39 | 2019 | |
| Exeltis, USA INC. | $56.33 | 2019-2025 | Slynd |
| Novo Nordisk INC | $54.08 | 2023-2024 | Wegovy |
| Organon LLC | $34.55 | 2023-2024 | Nexplanon |
| Pfizer INC. | $33.04 | 2024-2025 | |
| Agile Therapeutics, INC. | $31.72 | 2021-2022 | |
| Minerva Surgical, INC | $26.50 | 2019 | |
| Olympus America INC. | $25.82 | 2019 | |
| Allergan, INC. | $23.52 | 2019 | |
| Kci USA, INC. | $20.20 | 2019 |
Show all 20 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Molnlycke Health Care US, LLC | $19.44 | 2023 | Mepilex Ag, Mepilex Border Em, Mepilex Border Flex |
| Therapeuticsmd, INC. | $18.82 | 2022 | |
| Lupin INC. | $17.29 | 2019 | |
| Mayne Pharma Commercial LLC | $16.19 | 2025 | |
| Coopersurgical, INC. | $14.06 | 2025 | Insorb |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Laura Wolfe listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.